Guidance for merged R&D scheme published
Companies claiming tax relief for research and development (R&D) will need to use the new merged scheme for accounting periods starting on 1 April 2024. Guidance on the new scheme has now been published. What are the key changes?

For accounting periods beginning before 1 April 2024, smaller companies could access a separate R&D scheme. Historically, this has been more generous than the relief available to large companies. Under the new scheme, SMEs will use the same framework as large companies to claim R&D expenditure credits (RDEC), unless they qualify for the narrowly drawn intensive scheme.
The main difference a small company will need to be aware of is the mechanics of the claim. The merged RDEC scheme involves adding a taxable credit to profits, then deducting it from the corporation tax liability. The SME scheme was a simple enhanced deduction. There are other changes too though. You will need to be aware of the rules regarding subcontracted expenses if you want to include these costs in your claim. There are also restrictions on the relief, e.g. relative to the company’s PAYE liability.
The new guidance is a handy overview and starting point. However, if your claim isn’t straightforward it is advisable to seek specialist advice.
Related Topics
-
Simpler Recycling rules take effect
New rules on how workplaces must sort their waste and recycling have taken effect from 31 March. What are the key changes to be aware of?
-
New CGT reporting tool
Self-assessment returns aren’t set up for the change in capital gains tax (CGT) rates on the government filing system and will require a manual adjustment for 2024/25 to ensure the correct amount is paid. Why is there a problem and can a new online tool help?
-
MONTHLY FOCUS: THE ENTERPRISE INVESTMENT SCHEME QUALIFYING CONDITIONS
The enterprise investment scheme (EIS) is a generous collection of tax reliefs aimed at encouraging private investment into relatively young companies. In this Focus, we look at the qualifying conditions relating to the investor and the issuing company that must be met in order for a claim for relief to succeed.